Published in Biotech Law Weekly, October 29th, 2004
M. Tartagni, University of Bari, and colleagues "[evaluated] the effectiveness and clinical usefulness of the hypo-osmotic swelling (HOS) test in predicting successful conception in couples in which men with mild male-factor infertility criteria were undergoing a timed vaginal intercourse protocol."
They analyzed semen samples from the men in 100 couples in which mild male infertility was the only abnormality. "Semen was analyzed according to standard World Health Organization (WHO) criteria and subjected to the HOS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.